Carboxylation of Kinetically Inert Platinum(IV) Hydroxy Complexes. An Entr.acte.ee into Orally Active Platinum(IV) Antitumor Agents.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Inorganic Chemistry

• Publication date

  1995-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/ic00109a004PMID 20000850
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preparation, characterization, and antitumor activity of new ethylenediamine platinum(IV) complexes containing mixed carboxylate ligands.

  1993cited by this paper
• Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.

  1993cited by this paper
• Synthesis and antitumor activity of ammine/amine platinum(II) and (IV) complexes.

  1993cited by this paper
• Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes.

  1992cited by this paper
• Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin and amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines.

  1992cited by this paper
• Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines.

  1992cited by this paper
• Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.

  1992cited by this paper
• Anticancer activity in murine and human tumor cell lines of bis(platinum) complexes incorporating straight-chain aliphatic diamine linker groups.

  1992cited by this paper
• Platinum, palladium, and lead levels in populations of Southern California.

  1976cited by this paper

• Synthesis, crystal structural description, DNA binding, molecular docking, and anticancer evaluation of the novel platinum(IV) supramolecular complex

  2025cites this paper
• Modulating C 2 Selectivity in CO 2 Electroreduction through Molecular Surface Engineering of Copper Nanowires

  2025cites this paper
• Coupling approaches for [Pt(1,10-phenanthroline)(1S,2S-diamminocyclohexane)dihydroxide]2+ using hydrazone and oxime ligation.

  2025cites this paper
• Advances and perspectives in phototherapy-based combination therapy for cancer treatment.

  2024cites this paper
• Endowing Pt(IV) with Perfluorocarbon Chains and Human Serum Albumin Encapsulation for Highly Effective Antitumor Chemoimmunotherapy.

  2024cites this paper
• The full spectrum of SLC22 OCT1 mutations illuminates the bridge between drug transporter biophysics and pharmacogenomics.

  2024cites this paper
• Promising Anticancer Prodrugs Based on Pt(IV) Complexes with Bis-organosilane Ligands in Axial Positions.

  2024cites this paper
• Strategy to Regulate the Stability and Reduction Rate of Oxaliplatin-Based Pt(IV) Complexes: Cocrystallization

  2023cites this paper
• Cancer cell membrane fused liposomal platinum(IV) prodrugs overcome cisplatin resistance in esophageal squamous cell carcinoma chemotherapy.

  2023cites this paper
• Synthesis, structure, and cytotoxicity of platinum(iv) complexes bearing aminoxyl and dichloroacetate ligands

  2023cites this paper
• The full spectrum of OCT1 (SLC22A1) mutations bridges transporter biophysics to drug pharmacogenomics

  2023cites this paper
• Oxidation of the Platinum(II) Anticancer Agent [Pt{(p-BrC6F4)NCH2CH2NEt2}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide

  2023cites this paper
• Computational Exploration of the Synergistic Anticancer Effect of a Multi-Action Ru(II)–Pt(IV) Conjugate

  2022cites this paper
• Synthesis, spectral, antioxidant, in vitro cytotoxicity activity and thermal analysis of Schiff base metal complexes with 2,2′-Bipyridine-4,4′-dicarboxylic acid as co-ligand

  2022cites this paper
• Dual-Action Pt(IV) Prodrugs and Targeted Delivery in Metal-Organic Frameworks: Overcoming Cisplatin Resistance and Improving Anticancer Activity

  2022cites this paper
• Microwave-Assisted Synthesis: Can Transition Metal Complexes Take Advantage of This “Green” Method?

  2022cites this paper
• Bioactivity studies of two copper complexes based on pyridinedicarboxylic acid N-oxide and 2,2′-bipyridine

  2022cites this paper
• Potential Anticancer Activities and Catalytic Oxidation Efficiency of Platinum(IV) Complex

  2022cites this paper
• What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives

  2021cites this paper
• Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake?

  2021cites this paper
• Pt(IV) Anticancer Prodrugs – A Tale of Mice and Men

  2021cites this paper
• The influence of different carbonate ligands on the hydrolytic stability and reduction of platinum(IV) prodrugs.

  2021cites this paper
• Atomic Layer Nucleation Engineering: Inhibitor-Free Area-Selective Atomic Layer Deposition of Oxide and Nitride

  2021cites this paper
• In Vitro Nephrotoxicity Studies of Established and Experimental Platinum-Based Compounds

  2021cites this paper
• Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas

  2021cites this paper
• Diverse and unexpected outcomes from oxidation of the platinum(II) anticancer agent [Pt{(p-BrC6F4)NCH2CH2NEt2}Cl(py)] by hydrogen peroxide.

  2021cites this paper
• Electron Delocalization in Spectroelectrochemically and Computationally Characterized [Pt{(p-BrC6F4)NCH═C(Cl)NEt2}Cl(py)]+ Formed by Electrochemical Oxidation of [PtII{(p-BrC6F4)NCH═C(Cl)NEt2}Cl(py)].

  2021cites this paper
• Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?

  2021cites this paper
• Platinum(iv)-azido monocarboxylato complexes are photocytotoxic under irradiation with visible light†

  2021cites this paper
• Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules.

  2020cites this paper
• Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues.

  2020cites this paper
• Platinum Complexes in Medicine and in the Treatment of Cancer

  2020cites this paper
• DNA Nanostructures as Pt(IV) Prodrug Delivery Systems to Combat Chemoresistance.

  2020cites this paper
• Recent Advances in the Chemistry of Metal Carbamates

  2020cites this paper
• Comparison of the Effect of Platinum (IV) Complexes on Spheroids and Monolayer Culture of HeLa Cells

  2020cites this paper
• trans-Platinum(iv) pro-drugs that exhibit unusual resistance to reduction by endogenous reductants and blood serum but are rapidly activated inside cells: 1H NMR and XANES spectroscopy study.

  2020cites this paper
• Axial functionalisation of photoactive diazido platinum(iv) anticancer complexes

  2020cites this paper
• Semiconducting quantum dots: Modification and applications in biomedical science

  2020cites this paper
• Design of Protein-Targeted Organometallic Complexes as Anticancer Agents.

  2019cites this paper
• A view on multi-action Pt(IV) antitumor prodrugs

  2019cites this paper
• Platinum(II) complexes containing hydrazide‐based aminophosphine ligands: Synthesis, molecular structures, computational investigation and evaluation as antitumour agents

  2019cites this paper
• Multi-action Pt(IV) anticancer agents; do we understand how they work?

  2019cites this paper
• Barrier potentials, molecular structure, force filed calculations and quantum chemical studies of some bipyridine di-carboxylic acids using the experimental and theoretical using (DFT, IVP) approach

  2019cites this paper
• Photocytotoxic Pt(iv) complexes as prospective anticancer agents.

  2019cites this paper
• Expanding the Arsenal of PtIV Anticancer Agents; Multi-action PtIV Anticancer Agents with Bioactive Ligands Possessing Hydroxyl Functional Group.

  2019cites this paper
• Recent progress in polymer-based platinum drug delivery systems

  2018cites this paper
• Current Status for Oral Platinum (IV) Anticancer Drug Development

  2018cites this paper
• Drug Combination Synergy in Worm-like Polymeric Micelles Improves Treatment Outcome for Small Cell and Non-Small Cell Lung Cancer.

  2018cites this paper
• Insights from Computations on the Mechanism of Reduction by Ascorbic Acid of PtIV Prodrugs with Asplatin and Its Chlorido and Bromido Analogues as Model Systems.

  2018cites this paper
• Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells

  2017cites this paper
• Exploring the Hydrolytic Behavior of the Platinum(IV) Complexes with Axial Acetato Ligands.

  2017cites this paper
• The effect of incorporating carboxylic acid functionalities into 2,2′-bipyridine on the biological activity of the complexes formed: synthesis, structure, DNA/protein interaction, antioxidant activity and cytotoxicity

  2017cites this paper
• Platinum coordination compounds with potent anticancer activity

  2017cites this paper
• Platinum(IV) Prodrugs – A Step Closer to Ehrlich's Vision?

  2017cites this paper
• Mono-functionalized glycosylated platinum(IV) complexes possessed both pH and redox dual-responsive properties: Exhibited enhanced safety and preferentially accumulated in cancer cells in vitro and in vivo.

  2017cites this paper
• Impact of the equatorial coordination sphere on the rate of reduction, lipophilicity and cytotoxic activity of platinum(IV) complexes.

  2017cites this paper
• Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy.

  2017cites this paper
• Synthesis, Characterization, and Cytotoxicity of the First Oxaliplatin Pt(IV) Derivative Having a TSPO Ligand in the Axial Position

  2016cites this paper
• A Lipophilic Pt(IV) Oxaliplatin Derivative Enhances Antitumor Activity.

  2016cites this paper
• More of a misunderstanding than a real mismatch? Platinum and its affinity for aqua, hydroxido, and oxido ligands

  2016cites this paper
• Multifunctional Pt(II) Reagents: Covalent Modifications of Pt Complexes Enable Diverse Structural Variation and In-Cell Detection.

  2016cites this paper
• Platinum(iv) anticancer prodrugs - hypotheses and facts.

  2016cites this paper
• The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs.

  2016cites this paper
• Glassy carbon electrodes deliver unpredictable reduction potentials for platinum(IV) antitumor prodrugs

  2016cites this paper
• Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c5sc04205d

  2016cites this paper
• A new member of the cationic dinitrosyl iron complexes family incorporating N-ethylthiourea is effective against human HeLa and MCF-7 tumor cell lines

  2016cites this paper
• On the stability of Pt(IV) pro-drugs with haloacetato ligands in the axial positions.

  2015cites this paper
• New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells.

  2015cites this paper
• Investigation into Catalytic Metallodrugs that Target Hepatitis C IRES RNA: Development, Characterization, and Mechanism

  2015cites this paper
• Synthesis and Platinum (II) Complexes of Different Polyazacyclophane Receptors

  2015cites this paper
• A theranostic prodrug delivery system based on Pt(IV) conjugated nano-graphene oxide with synergistic effect to enhance the therapeutic efficacy of Pt drug.

  2015cites this paper
• Bis- and Tris(carboxylato)platinum(IV) Complexes with Mixed Am(m)ine Ligands in the trans Position Exhibiting Exceptionally High Cytotoxicity

  2015cites this paper
• Bis‐ and Tetrakis(carboxylato)platinum(IV) Complexes with Mixed Axial Ligands – Synthesis, Characterization, and Cytotoxicity

  2015cites this paper
• Host–guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins

  2015cites this paper
• Tumor microenvironment in focus: LA-ICP-MS bioimaging of a preclinical tumor model upon treatment with platinum(IV)-based anticancer agents.

  2015cites this paper
• A new entry to asymmetric platinum(IV) complexes via oxidative chlorination.

  2014cites this paper
• Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands.

  2014cites this paper
• Oxidative halogenation of cisplatin and carboplatin: synthesis, spectroscopy, and crystal and molecular structures of Pt(IV) prodrugs.

  2014cites this paper
• A Breast Cancer Stem Cell-Selective, Mammospheres-Potent Osmium(VI) Nitrido Complex

  2014cites this paper
• Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: how long the organic chain should be?

  2014cites this paper
• Improvements in the Synthesis and Understanding of the Iodo-bridged Intermediate en Route to the Pt(IV) Prodrug Satraplatin.

  2014cites this paper
• Comparative in vitro and in vivo pharmacological investigation of platinum(IV) complexes as novel anticancer drug candidates for oral application

  2014cites this paper
• Reinterpretation of the vibrational spectroscopy of the medicinal bioinorganic synthon c,c,t-[Pt(NH3)2Cl2(OH)2]

  2014cites this paper
• Understanding intrinsically irreversible, non-Nernstian, two-electron redox processes: a combined experimental and computational study of the electrochemical activation of platinum(IV) antitumor prodrugs.

  2014cites this paper
• Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes.

  2014cites this paper
• Synthesis, biological evaluation and SAR studies of novel bicyclic antitumor platinum(IV) complexes.

  2014cites this paper
• The Chiral Potential of Phenanthriplatin and Its Influence on Guanine Binding

  2014cites this paper
• Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery

  2014cites this paper
• Platinum(IV) cisplatin derivative trans, cis, cis-bis(heptanoato)amine(cyclohexylamine)dichloridoplatinum(IV) has an enhanced therapeutic index compared to cisplatin for the treatment of non-small cell lung cancer

  2014cites this paper
• Ruthenium(II) complexes of 2,2′-bipyridine-5,5′-dicarboxylic acid: Synthesis, structure, DNA binding, cytotoxicity and antioxidant activity

  2013cites this paper
• Influence of equatorial and axial carboxylato ligands on the kinetic inertness of platinum(IV) complexes in the presence of ascorbate and cysteine and within DLD-1 cancer cells.

  2013cites this paper
• Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells.

  2013cites this paper
• A core cross-linked polymeric micellar platium(IV) prodrug with enhanced anticancer efficiency.

  2013cites this paper
• Facile preparation of mono-, di- and mixed-carboxylato platinum(IV) complexes for versatile anticancer prodrug design.

  2013cites this paper
• Synthetic methods for the preparation of platinum anticancer complexes.

  2013cites this paper
• Synthesis and characterization of Novel Di- and Tetracarboxylatoplatinum(IV) complexes

  2013cites this paper
• The effect of ligand lipophilicity on the nanoparticle encapsulation of Pt(IV) prodrugs.

  2013cites this paper
• Monofunctional and higher-valent platinum anticancer agents.

  2013cites this paper
• Bulky N(,N)-(di)alkylethane-1,2-diamineplatinum(II) compounds as precursors for generating unsymmetrically substituted platinum(IV) complexes.

  2013cites this paper
• Molecular interaction fields vs. quantum-mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes.

  2013cites this paper